These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 36092245)

  • 1. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.
    Li DF; Yang MF; Xu J; Xu HM; Zhu MZ; Liang YJ; Zhang Y; Tian CM; Nie YQ; Shi RY; Wang LS; Yao J
    Int J Nanomedicine; 2022; 17():3893-3911. PubMed ID: 36092245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms.
    Yang B; Chen Y; Shi J
    Adv Mater; 2019 Jan; 31(2):e1802896. PubMed ID: 30126052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles and exosome-like nanovesicles as pioneering oral drug delivery systems.
    Mondal J; Pillarisetti S; Junnuthula V; Surwase SS; Hwang SR; Park IK; Lee YK
    Front Bioeng Biotechnol; 2023; 11():1307878. PubMed ID: 38260737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease.
    Shen Q; Huang Z; Yao J; Jin Y
    J Adv Res; 2022 Mar; 37():221-233. PubMed ID: 35499059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
    Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
    Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli-Derived Outer Membrane Vesicles Relay Inflammatory Responses to Macrophage-Derived Exosomes.
    Imamiya R; Shinohara A; Yakura D; Yamaguchi T; Ueda K; Oguro A; Minamiyama Y; Ichikawa H; Horiguchi Y; Osada-Oka M
    mBio; 2023 Feb; 14(1):e0305122. PubMed ID: 36648227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cells-Derived Extracellular Vesicles: Potential Therapeutics for Wound Healing in Chronic Inflammatory Skin Diseases.
    Manchon E; Hirt N; Bouaziz JD; Jabrane-Ferrat N; Al-Daccak R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired and bioderived nanomedicine for inflammatory bowel disease.
    Gazzi R; Gelli R; Aleandri S; Carone M; Luciani P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1986. PubMed ID: 39140489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-mediated effects and applications in inflammatory bowel disease.
    Ocansey DKW; Zhang L; Wang Y; Yan Y; Qian H; Zhang X; Xu W; Mao F
    Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1287-1307. PubMed ID: 32410383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology.
    Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biogenesis, Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles.
    Gurunathan S; Kang MH; Qasim M; Khan K; Kim JH
    Int J Nanomedicine; 2021; 16():3357-3383. PubMed ID: 34040369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Roles of Extracelluar Vesicles Derived from Bacteria, Mammalian or Plant Cells in the Pathogenesis and Clinical Application of Neurodegenerative Diseases.
    Li Y; Zhou C; Liu H; Cai T; Fan H
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles with Possible Roles in Gut Intestinal Tract Homeostasis and IBD.
    Chang X; Wang SL; Zhao SB; Shi YH; Pan P; Gu L; Yao J; Li ZS; Bai Y
    Mediators Inflamm; 2020; 2020():1945832. PubMed ID: 32410847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome Theranostics: Biology and Translational Medicine.
    He C; Zheng S; Luo Y; Wang B
    Theranostics; 2018; 8(1):237-255. PubMed ID: 29290805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-Induced Regulation in Inflammatory Bowel Disease.
    Zhang H; Wang L; Li C; Yu Y; Yi Y; Wang J; Chen D
    Front Immunol; 2019; 10():1464. PubMed ID: 31316512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.